Modal

2024 CLARITY Program     continue reading →

Solution for improved delirium management

World's first objective measure of patient brain state

DeltaScan® Brain State Monitor provides a quick and objective measurement of acute encephalopathy (acute brain failure, which encompasses delirium) with high diagnostic performance to support timely interventions

Solution for improved delirium management

World's first objective measure of patient brain state

DeltaScan® Brain State Monitor provides a quick and objective measurement of acute encephalopathy (acute brain failure, which encompasses delirium) with high diagnostic performance to support timely interventions

A Top Public Health Priority

Acute Brain Failure | Delirium is the Most Common Post-op Complication in Older Adults 

Each year, approximately 50% of surgical and ICU patients in the US and Europe are at risk of developing acute brain failure and delirium¹.

In the US the annual health system and societal costs are estimated at $164B, rivaling costs associated with heart disease and diabetes².

prolira-deltascan-us
YET...

“Up to 88% of delirious patients go undetected in daily care practice³”

Marcantonio, 2017, The New England Journal of Medicine

Let’s improve on that

DeltaScan® adds quantitative brain state data to the diagnostic process
Stay up to date with the latest news and upcoming events from Prolira DeltaScan®
prolira-deltascan-delirium
Our Journey So Far

Prolira Achievements to Date 

Exclusive technology license from University Medical Centre Utrecht
Product Development and 434 patient Multi-Center Study
3 clinical studies completed and enrolling in more
CE certified according to EU MDR since 2020
FDA Clearance
Establishing Clinical & Strategic Partnerships 

Interested? Let's get in touch!

Get in touch to learn how you can reshape your acute brain failure | delirium care delivery

sources: ¹ American Geriatric Society ² Inouye et al. 2014 ³ Marcantonio, et al. N Engl J Med 2017

pageversion: 1.0